Therapy Market Research Reports & Industry Analysis

Analyse the latest global RA market players and products, and start mapping your future market parameters with Therapy Trends’ Consensus Outlook: Rheumatoid Arthritis, which includes the following com...

What the future holds Over the next few years, the global Rheumatoid Arthritis (RA) market is expected to grow from $16.5 billion in 2011 to $23.4 billion in 2016. This expansion of the market will b...

Therapy Trends KOL Insight: Rheumatoid Arthritis analyses the current and predicted key issues, clinical advances and late-stage pipeline products in the international and US RA markets. KOL Insight g...

Gilead’s supremacy in the HIV space in 2012-18 should remain intact with the successful launch of ... , please read our report released on 3rd May, 2012 on Gilead titled “After HIV -Poised to Deliver the Best Anti-Viral Treatment Options for HCV!”

... , pelvic inflammatory diseases, etc. Today, arrays of treatment options to treat infertility are readily available in India. These include medications for ovulation induction ... IUI, IVF, and ICSI (intra cytoplasmic sperm injection). India has become one of the favored destinations for infertility treatments such as IVF due to several ...

This report analyzes the worldwide markets for Osteoporosis Therapeutics in US$ Million by the following Therapeutic Classes: Bisphosphonates, ERT Drugs, SERMs, Calcitonins, ... 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 49 companies including many key and niche ...

This report analyzes the worldwide markets for Herpes Simplex Virus Treatment in US$ Million. The report provides separate comprehensive analytics for the US, ... , Inc., Novartis International AG, Sanofi, Starpharma Holdings Limited, and Vical. Market data and analytics are derived from primary and secondary ...

Protein-based therapies have found a prominent place in the biopharmaceutical industry since the launch of human insulin product. They have become one of the most effective clinical methods to treat w...

An incisive report and dynamic analyst briefing service delivering insight from the most influential Multiple Sclerosis (MS) Key Opinion Leaders to map the current treatment landscape and analyse futu...

In this updated issue of ‘Japan-Domestic Pharma Market Summary’ for 2012, we present major 10 Thx Class in Japan which covers ~40% of total Japan domestic pharma market (~¥8.0 trillion). This will ... breakthroughs in each class – which includes products from all pharma companies operating in Japan including MNCs.

... with G551D mutation), we see little risk to Vertex (VRTX) profitability for at least next three years ... of IL28B CC Genotype. Vertex has also accelerated the pace of developing IFN-free drugs to remain in the ... 14th Feb., 2012 on Vertex titled “IFN-free Oral HCV Treatment – Vertex Not Out of the Race Yet ...

Gilead (GILD) is poised for further growth, based on the FY12 ... GILD a step closer towards its goal to deliver the “best-in-class IFN-free oral pill” for HCV. Other acquisitions ... read our report released on 10th Feb., 2012 on Gilead Sciences titled “Providing the Best Antiviral Treatment Options for HIV and HCV!”

This report analyzes the Global market for Gene Therapy in US$ Million. Annual estimates and forecasts are provided for the period 2009 through ... GenVec, Oxford BioMedica, Shenzhen SiBiono GeneTech Co., Ltd., Transgene, and Vical Inc. Market data and analytics are derived from primary and secondary research. ...

... anecdotes, market briefs, and concise summaries of research findings. The report offers an aerial view of the global oxygen therapy industry, identifies major short to medium term market challenges, and growth drivers. Regional markets elaborated upon include United States ...

HIV endemic has had devastating economic, social, health and psychological impacts over the years affecting millions of households in a significant manner over the last decade. Despite the concrete ef...

The present Competitive Intelligence report about HIV Small Molecule Therapeutics used to treat human immunodeficiency virus (HIV) infections provides a competitor evaluation in the field of marketed...

This report analyzes the worldwide markets for Autoimmune Disease Therapeutics in US$ Million by the following Therapeutic Class: Rheumatoid Arthritis (Biologics), Multiple ... 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 112 companies including many key and niche ...

This report analyzes the worldwide markets for Multiple Myeloma Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US, ... , Inc., Millennium Pharmaceuticals, Seattle Genetics, and Ziopharm Oncology, Inc. Market data and analytics are derived from primary and secondary ...

This report analyzes the worldwide markets for Overactive Bladder (OAB) Therapeutics in US$ Million. The report provides separate comprehensive analytics for ... ., SALVAT Biotech, Sepracor Pharmaceuticals, Inc., and Watson Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary ...

This report analyzes the worldwide markets for Irritable Bowel Syndrome (IBS) Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year ...

Single User PDF Format: US$ 1,800.00 Multi-User License: US$ 2,800.00 Hard Copy: US$ 2,200.00 CD-ROM: US$ 2,200.00 Within the global pharmaceutical industry, protein therapeutics has b...

Medivir’s Xerese fetched $45m for the company from Meda AB for US, ... , please read our report released on 29th June on MVIR titled “Monetizing Cold Sores to Focus On Improved Protease Inhibitors for HCV Treatment” and ...

... online work with the project data to print or export an individual report. Although there are only two approved and marketed RNA based ... CpG Oligonucleotides Corporate Clinical Stage RNA Therapeutics R&D Pipelines About Competitor Analysis Series: The Competitor Analysis Series delivers NO-FRILLS, but ...

... aminopeptidase 2 (MetAP2) Inhibitors f) Other Metabolic Modifiers 6) Various Approaches 7) Unspecified Targets Corporate Targeted Therapy of Obesity R&D Pipelines About Competitor Analysis Series: The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D ...

... (RNAi) or Locked Nucleic Acid (LNA) RNA. Each project is specified for its Target or Mechanism of Action, Therapeutic Area and R&D Phase. Use of ... illustrate the database. Purchase of the subscription provides a 1-year online access to the data of the RNA Therapeutics Pipeline Database. Credentials to access ...

The global radiation therapy market has witnessed a double digit growth rate during the last ... from developing nations. The report provides an in-depth analysis of the global radiation therapy market. The various drivers, opportunities and the challenges faced by the ...

This report analyzes the Global market for Narcolepsy Therapeutics in US$ Million. Annual estimates and forecasts are provided for the period 2006 ... , Inc., Cephalon, Inc., Evotec AG, Hypnion, Inc., and Jazz Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary research. ...

This report analyzes the worldwide markets for ADHD Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US and ... , Novartis AG, Shire Plc, UCB S.A., Companies with Drugs in Pipeline for ADHD: Abbott Laboratories, Inc., Cortex Pharmaceuticals, Inc., KemPharm, Inc., and ...

This report analyzes the Global market for Inflammatory Bowel Disease Therapeutics in US$ Million. Annual estimates and forecasts are provided for the ... Pharmaceutical Co.Ltd., Prometheus Laboratories, Inc., Shire plc, UCB SA, and Wyeth. Market data and analytics are derived from primary and secondary ...

This report analyzes the Global market for Tuberculosis Therapeutics in US$ Million. Annual estimates and forecasts are provided for the period 2006 ... SA, Summit Plc, Tibotec BVBA, Otsuka Pharmaceutical Co., Ltd., and Sequella, Inc. Market data and analytics are derived from primary and secondary research. ...

This report analyzes the worldwide markets for Multiple Sclerosis Therapeutics in US$ Billion. The report provides separate comprehensive analytics for the US, Japan, Europe and Rest of World. Annual estimates and forecasts are provided for each region for the period 2006 through 2015. The report profiles ...

This report analyzes the worldwide markets for Melanoma Therapeutics in US$ Million. The report provides separate comprehensive analytics for US, and Rest of ... through 2015. Also, a six-year historic analysis is provided for these markets. The report profiles 73 companies including many key and niche players ...

This report analyzes the worldwide markets for Dyslipidemia Therapeutics in US$ Million by the following segments - Statins, and Non-Statins. The report provides ... Mylan, Inc., Novartis AG, Pfizer, Inc., and Teva Pharmaceutical Industries Ltd. Market data and analytics are derived from primary and secondary ...

This report analyzes the worldwide markets for Lymphoma Therapeutics in US$ Million. The report provides separate comprehensive analytics for US, Europe, and ... ., ImmunoGen, Inc., InNexus Biotechnology, Inc., and Millennium Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary ...

... a hyperlink leading to the source of information. Index Proteins & peptides Antibodies Vaccines Corporate R&D Pipelines of Biologic and Immuno Therapeutics of S. aureus infections About La Merie About Competitor Analysis Series The Competitor Analysis Series delivers NO-FRILLS, but concise ...

This report analyzes the worldwide markets for Rheumatoid Arthritis Therapeutics in US$ Million.The report provides separate comprehensive analytics for US, Japan, ... Johnson & Johnson Services, Inc., Schering-Plough Corp., UCB S.A., and Wyeth. Market data and analytics are derived from primary and secondary ...

... targeted therapy of prostate and other cancers. Prostate-specific antigen (PSA) was discovered more than 20 years ago and has become the ... PSA Targeted Therapy Corporate PSMA & PSA Targeted Therapy R&D Pipelines About La Merie About Competitor Analysis Series The Competitor Analysis Series delivers ...

... . The global market for autoimmune disease treatments is estimated to be at $37.84 billion in 2009, and is growing at a CAGR of 12.7% from 2009 to 2014 to reach an estimated $68.81 billion in 2014. The effects of the global ... 2009 to 2014. Scope of the Report The report provides market overviews and forecasts as well as market drivers and restraints for the global autoimmune treatment ...

... globally. The dialysis care market has seen major growth in the last few years and in this segment – the most preferred method of treatment continues to be hemodialysis ...

... proton therapy market. Key Highlights of the United States Proton Therapy Market Report: Proton Therapy Current Applications Pros and Cons of Proton Therapy, Radiotherapy and Carbon Ion Therapy Proton Therapy Competitive Analysis: By Company Market Size & Analysis: United States Proton Therapy ...

Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request. This report will be delivered in 7-10 workin...

Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request. This report will be delivered in 1-5 working...